Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
PIK3CA mutations appear to be the most common driver mutations in breast cancer, with H1047R and E545K being the most common, accounting for approximately 60% of all PIK3CA mutations, with good therapeutic implications. Given the low sensitivity and high cost of current genotyping methods, we offer a fast, simple and inexpensive assay for PIK3CA H1047R and E545K mutation screening in clinical materials.